JUNS (Jupiter Neurosciences) Tariff Resilience Score: 6/10 (As of Jul. 09, 2026)


JUNS Jupiter Neurosciences Inc JUNS
4 GF Score
Price $0.19
! 6 Warning Signs
View Full Analysis

What is Jupiter Neurosciences Tariff Resilience Score?

Jupiter Neurosciences JUNS -8.80% 4 Tariff Resilience Score is 6 as of Jul. 09, 2026. GuruFocus rates JUNS with a GF Score™ of 4/100. The stock has 6 warning signs investors should review. Among 1,367 Biotechnology companies, Jupiter Neurosciences ranks better than 75.93% on this metric.

Jupiter Neurosciences has the Tariff Resilience Score of 6, which implies that the company might have Average Resilient.

Jupiter Neurosciences has Moderate exposure due to reliance on global supply chains for raw materials. Manufacturing is primarily domestic, but sales are international. Historical tariffs have had limited impact. Mitigation through alternative suppliers is possible, but pricing power is limited.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Jupiter Neurosciences might have Average Resilient.

Jupiter Neurosciences  (NAS:JUNS) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Jupiter Neurosciences Tariff Resilience Score Related Terms

JUNS vs ZEOX, LEXX, GDTC: Tariff Resilience Score Comparison

For the Biotechnology subindustry, Jupiter Neurosciences's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Jupiter Neurosciences Tariff Resilience Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Jupiter Neurosciences's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Jupiter Neurosciences's Tariff Resilience Score falls into.


JUNS
4GF Score
Jupiter Neurosciences Inc JUNS
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 6 mean?
Jupiter Neurosciences (JUNS) has a Tariff Resilience Score of 6 as of Jul. 09, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Jupiter Neurosciences ranks #329 out of 1367 companies in the Biotechnology industry, placing it in the top 24.1%.
Is Jupiter Neurosciences' Tariff Resilience Score too high?
Jupiter Neurosciences' current Tariff Resilience Score is 6. The Biotechnology industry median Tariff Resilience Score is 4.00. Jupiter Neurosciences' value of 6 is 50% above this industry median. Based on the distribution chart, Jupiter Neurosciences ranks #329 out of 1367 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Jupiter Neurosciences has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Jupiter Neurosciences' Tariff Resilience Score compare to ZEOX and LEXX?
According to the Biotechnology industry distribution chart, Jupiter Neurosciences ranks #329 out of 1367 companies for Tariff Resilience Score. This places Jupiter Neurosciences in the top 24% of its industry — outperforming the majority of peers. The industry median Tariff Resilience Score is 4.00. Jupiter Neurosciences' value of 6 is 50% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Biotechnology company?
The median Tariff Resilience Score among Biotechnology companies is 4.00, based on 1,367 companies in the industry. Companies in the top quartile (top 25%) have a Tariff Resilience Score significantly above this median, while those in the bottom quartile fall well below. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jupiter Neurosciences's current Tariff Resilience Score of 6 is 50% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. For the Biotechnology industry, the median Tariff Resilience Score is 4.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jupiter Neurosciences's current Tariff Resilience Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jupiter Neurosciences stock overvalued right now?
Jupiter Neurosciences (JUNS) has a current Tariff Resilience Score of 6. The current Tariff Resilience Score is 6 and 50% above the Biotechnology industry median of 4.00. Jupiter Neurosciences' overall GF Score™ is 4/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Jupiter Neurosciences (JUNS), the current Tariff Resilience Score is 6 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Jupiter Neurosciences Business Description

Address 1001 North US Highway 1, Suite 504, Jupiter, FL, USA, 33477
Jupiter Neurosciences Inc is a clinical-stage research and development company focused on developing treatments for neuroinflammation through the resveratrol platform. Its platform product, JOTROL, is an enhanced oral formulation of resveratrol, which has many potential indications. In the larger disease areas, which are targeting Parkinson's Disease. The group is presently in the process of conducting a Phase IIa clinical trial in Parkinson's Disease. The company operates through two reportable segments: premium nutritional supplements and pharmaceutical operations focused on drug candidates for CNS and rare orphan diseases. It generates the majority of its revenue from Premium Nutritional Supplements, which includes commercialization and sales of the Company's Nugevia product line.
4GF Score

Get the complete analysis for JUNS

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.19
Price